369 related articles for article (PubMed ID: 34503302)
1. Role of Metastasis-Related microRNAs in Prostate Cancer Progression and Treatment.
Oh-Hohenhorst SJ; Lange T
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503302
[TBL] [Abstract][Full Text] [Related]
2. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
3. Identification of Key MicroRNAs and Mechanisms in Prostate Cancer Evolution Based on Biomarker Prioritization Model and Carcinogenic Survey.
Lin Y; Miao Z; Zhang X; Wei X; Hou J; Huang Y; Shen B
Front Genet; 2020; 11():596826. PubMed ID: 33519899
[No Abstract] [Full Text] [Related]
4. Different levels of serum microRNAs in prostate cancer and benign prostatic hyperplasia: evaluation of potential diagnostic and prognostic role.
Cochetti G; Poli G; Guelfi G; Boni A; Egidi MG; Mearini E
Onco Targets Ther; 2016; 9():7545-7553. PubMed ID: 28008272
[TBL] [Abstract][Full Text] [Related]
5. Copy number gain of ZEB1 mediates a double-negative feedback loop with miR-33a-5p that regulates EMT and bone metastasis of prostate cancer dependent on TGF-β signaling.
Dai Y; Wu Z; Lang C; Zhang X; He S; Yang Q; Guo W; Lai Y; Du H; Peng X; Ren D
Theranostics; 2019; 9(21):6063-6079. PubMed ID: 31534537
[No Abstract] [Full Text] [Related]
6. Multivariate competing endogenous RNA network characterization for cancer microRNA biomarker discovery: a novel bioinformatics model with application to prostate cancer metastasis.
Lin Y; Qi X; Chen J; Shen B
Precis Clin Med; 2022 Mar; 5(1):pbac001. PubMed ID: 35821682
[TBL] [Abstract][Full Text] [Related]
7. miR-582-3p and miR-582-5p Suppress Prostate Cancer Metastasis to Bone by Repressing TGF-β Signaling.
Huang S; Zou C; Tang Y; Wa Q; Peng X; Chen X; Yang C; Ren D; Huang Y; Liao Z; Huang S; Zou X; Pan J
Mol Ther Nucleic Acids; 2019 Jun; 16():91-104. PubMed ID: 30852380
[TBL] [Abstract][Full Text] [Related]
8. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
[TBL] [Abstract][Full Text] [Related]
9. Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
Ma H; Wang LY; Yang RH; Zhou Y; Zhou P; Kong L
J Cell Biochem; 2019 Oct; 120(10):17779-17790. PubMed ID: 31127646
[TBL] [Abstract][Full Text] [Related]
10. Biomarker microRNAs for prostate cancer metastasis: screened with a network vulnerability analysis model.
Lin Y; Chen F; Shen L; Tang X; Du C; Sun Z; Ding H; Chen J; Shen B
J Transl Med; 2018 May; 16(1):134. PubMed ID: 29784056
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LINC00963 induces NOP2 expression by sponging tumor suppressor miR-542-3p to promote metastasis in prostate cancer.
Sun F; Wu K; Yao Z; Mu X; Zheng Z; Sun M; Wang Y; Liu Z; Zhu Y
Aging (Albany NY); 2020 Jun; 12(12):11500-11516. PubMed ID: 32554858
[TBL] [Abstract][Full Text] [Related]
12. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
13. Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction.
Bidarra D; Constâncio V; Barros-Silva D; Ramalho-Carvalho J; Moreira-Barbosa C; Antunes L; Maurício J; Oliveira J; Henrique R; Jerónimo C
Front Oncol; 2019; 9():900. PubMed ID: 31572685
[TBL] [Abstract][Full Text] [Related]
14. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
15. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
16. microRNA Expression Profiling in Young Prostate Cancer Patients.
Valera VA; Parra-Medina R; Walter BA; Pinto P; Merino MJ
J Cancer; 2020; 11(14):4106-4114. PubMed ID: 32368293
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs and epithelial-mesenchymal transition in prostate cancer.
Sekhon K; Bucay N; Majid S; Dahiya R; Saini S
Oncotarget; 2016 Oct; 7(41):67597-67611. PubMed ID: 27588490
[TBL] [Abstract][Full Text] [Related]
18. miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial-mesenchymal transition.
Zhang X; Zhang T; Yang K; Zhang M; Wang K
Onco Targets Ther; 2016; 9():6909-6914. PubMed ID: 27877055
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
[TBL] [Abstract][Full Text] [Related]
20. Biomarker Potential of Plasma MicroRNA-150-5p in Prostate Cancer.
Paunescu IA; Bardan R; Marcu A; Nitusca D; Dema A; Negru S; Balacescu O; Balacescu L; Cumpanas A; Sirbu IO; Petrut B; Seclaman E; Marian C
Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31484346
[No Abstract] [Full Text] [Related]
[Next] [New Search]
